2022
DOI: 10.3892/etm.2022.11421
|View full text |Cite
|
Sign up to set email alerts
|

Research progress of signaling pathways of the natural substances intervene dyslipidemia (Review)

Abstract: Dyslipidemia is an umbrella term for a range of lipid metabolic disorders in the body. This condition has been widely reported to greatly increase the risk of cardiovascular diseases, threatening human health. In recent years, advances in molecular biology have deepened understanding of the dyslipidemia-related signaling pathways and specific mechanisms underlying dyslipidemia. Signaling pathways possess the ability to transmit an extracellular signal to the inside of the cell, leading to specific biological e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 79 publications
0
1
0
Order By: Relevance
“…Adipose tissue, an important endocrine organ in the human body, has various signal pathway networks, whose function depends on the synthesis and release of cytokines [16] . The adipocytokine signaling pathway belongs to the signaling pathways related to dyslipidemia [17] . A study has shown that the fluid shear stress of arteries directly regulated the expression of interferon regulatory factors in arterial endothelial cells and downstream inflammatory response, which is an important mediator of dyslipidemia and atherosclerosis [18] .…”
Section: Discussionmentioning
confidence: 99%
“…Adipose tissue, an important endocrine organ in the human body, has various signal pathway networks, whose function depends on the synthesis and release of cytokines [16] . The adipocytokine signaling pathway belongs to the signaling pathways related to dyslipidemia [17] . A study has shown that the fluid shear stress of arteries directly regulated the expression of interferon regulatory factors in arterial endothelial cells and downstream inflammatory response, which is an important mediator of dyslipidemia and atherosclerosis [18] .…”
Section: Discussionmentioning
confidence: 99%